CVS Caremark Corp. and Cardinal Health Inc. will launch a joint venture that will serve as the largest generic drug sourcing entity in the U.S., the companies announced Tuesday.
Arizona officials have asked the U.S. Supreme Court to back its position that states may determine who qualifies as a Medicaid provider and revive a law denying funding to providers who perform elective abortions, according to a petition made available Monday.
Activist hedge fund Elliott Management Corp. said Tuesday that it would use its sizable minority stake in Celesio AG to stymie a €6.1 billion ($8.4 billion) takeover bid lobbed at the German drug distributor by California-based peer McKesson Corp.
A Tennessee federal judge found Monday that dozens of lawsuits against Quorum Health Resources LLC over allegedly botched surgeries constitute a single medical incident under a Lexington Insurance Co. policy, meaning Quorum only has to pay one self-insured retention before the Lexington coverage kicks in.
A Florida federal judge on Monday tossed Boca Radiation Oncology Associates’ suit accusing Comprehensive Cancer Centers LLC of breaching a management services agreement, saying BROA was not a third-party beneficiary of the deal.
A New Jersey federal judge on Monday junked a whistleblower’s False Claims Act suit accusing Express Scripts Inc. and other companies of using inflated average wholesale prices to devise a Medicaid overbilling scheme, ruling the public disclosure doctrine blocked the suit.
A New Jersey bankruptcy judge last week dealt a blow to Prime Healthcare Services Inc., upholding the sale of a bankrupt hospital and dismissing Prime’s lawsuit against the purchaser, which Prime said conspired to box the company out of the New Jersey hospital market.
A new inspector general's report indicates that federal regulators are relying on whistleblowers and corporate honesty instead of proactive audits to enforce privacy protections covering sensitive health information, suggesting many companies are getting a free pass on shoddy compliance, experts say.
Two Republican lawmakers want the Internal Revenue Service to share how it will protect taxpayer data in light of a September report indicating its computer system that calculates tax credits under the Affordable Care Act has security weaknesses, according to a letter released Monday.
A group of doctors who previously worked at the Weill Cornell Residency Program pushed back Friday against a hospital's bid to toss their class action, saying administrators should not be able to escape a decade-old fraud that robbed the doctors of millions in Federal Insurance Contributions Act, or FICA, tax refunds.
The U.S. Supreme Court on Monday denied Pfizer Inc.’s bid to rehear three First Circuit rulings related to its allegedly deceptive marketing of Neurontin, allowing to stand the First Circuit's determination that resulting off-label prescriptions harmed Kaiser Foundation Health Plan Inc. and others.
A Seattle jury on Thursday found two doctors, their employers and a hospital negligent and responsible for a surgical accident that set a Medtronic Inc. endotracheal tube on fire, awarding the victim $18 million but not finding Medtronic’s design of the tube to be negligent.
The First Circuit on Friday tossed a whistleblower’s closely watched False Claims Act suit accusing Takeda Pharmaceutical Co. Ltd. of defrauding Medicare by concealing drug risks, finding insufficient specifics but declining to endorse a district court’s ruling that such misconduct could never support FCA liability.
Doctors and hospitals will have to adapt in important ways because of Medicare’s newly announced payment changes for next year, but they also dodged some big financial bullets that could have hurt their bottom lines, experts say. Here are five highlights from the final rules on 2014 reimbursement.
The Centers for Medicare and Medicaid Services announced a one-year extension Friday of a deadline for doctors and hospitals to meet increasingly demanding standards for use of electronic health records, or EHRs.
A Texas grand jury indicted a former executive of a state cancer prevention institute on one felony charge stemming from alleged improprieties in an $11 million grant awarded to a pharmaceutical research firm, the Travis County District Attorney’s office said Friday.
One of the authors of a recent U.S. Chamber of Commerce report calling for an overhaul of the False Claims Act on Friday defended the report’s reform proposals, despite claims from a whistleblowers’ advocate that the act was an effective anti-fraud tool that did not need revision.
The Federal Trade Commission on Thursday shot back at claims that its data security suit against LabMD Inc. should be paused while the company challenges the regulator's allegations in the 11th Circuit and District of Columbia, saying the delay would undermine the commission's adjudicative processes.
A Connecticut federal judge ruled that United Healthcare Group cannot terminate more than 2,000 Connecticut physicians who are participating providers in its Medicare Advantage plan, saying Thursday that doing so would cause irreparable harm to the affected doctors in violation of their contract.
The states that opted out of the Affordable Care Act’s Medicaid expansion will see a net loss of $35.4 billion in taxpayer dollars per year, according to a study released Thursday.
No document review mechanism guarantees perfection, however, the adoption of predictive coding has the potential to drastically alter the way documents are reviewed and produced in complex pharmaceutical and medical device litigation, says Jessica Sykora of Norton Rose Fulbright.
The U.S. Supreme Court will have no shortage of issues to address concerning the rights of religious for-profit corporations in Hobby Lobby Stores Inc. v. Sebelius and Conestoga Wood Specialties Inc. v. Sebelius. Their answers will likely fracture the court — as they have the federal appellate courts — and could potentially lead to surprising results, say Darren Nadel and William Trachman at Littler Mendelson PC.
In light of the proposed e-discovery amendments to the Federal Rules of Civil Procedure, businesses need to set themselves up to efficiently respond to discovery and requests for information from their counsel by implementing and following document-control policies as part of normal business practices. The failure to do so will eventually consume vast amounts of employee time, say Steven Cvitanovic and Colin Murphy of Haight Brown & Bonesteel LLP.
The statutory and regulatory framework, marketplace, infrastructure and use of health information technology has grown and changed exponentially during the 2013 calendar year — but not without practical and legal challenges ranging from Affordable Care Act implementation to fraud and data protection concerns, say Sidney Welch and Cindy Acosta at Kilpatrick Townsend & Stockton LLP.
While the Obama administration delayed the employer mandate provision of the Affordable Care Act until next year, employers will soon have to determine whether an employee is classified as full-time and is therefore eligible for coverage — which may lead to staffing decisions that could expose them to liability. Remember, section 510 of ERISA generally prohibits interfering with employee benefits, say Adam Solander and Kara Maciel of Epstein Becker Green PC.
There are several unique defenses, depending on the state, available to defendant pharmaceutical companies which arise from the discord between consumer protection statutes and prescription drugs, say Yvonne McKenzie and Gabriel Vidoni at Pepper Hamilton LLP.
What is the thinking as to whether leaky air conditioner cases warrant multidistrict litigation treatment? On Dec. 5, the Judicial Panel on Multidistrict Litigation heads to Vegas to find out. This will bring a temperature shift in more ways than one from the September hearing, where the panel considered a potential MDL proceeding arising from allegedly defective clothes dryers, says Alan Rothman of Kaye Scholer LLP.
In addition to continued headline-grabbing litigation involving pharmaceutical companies in the wake of PLIVA Inc. v. Mensing, 2013 brought a number of important cases informing everything from class certification questions and product labeling trends to False Claims Act liability and fracking disputes, say attorneys at Weil Gotshal & Manges LLP.
China's Food and Drug Administration recently announced changes to its Drug Registration Rules, which, while demonstrating the agency’s determination to foster innovation, may not achieve a balance between multinational drug companies and domestic competitors in its current shape, says Katherine Wang of Ropes & Gray LLP.
A recent California appeals court decision provides a benchmark for plaintiffs to plead and prove claims under the California Medical Information Act that is consistent with prior nonhealth-care decisions. Plaintiffs must do more than plead mere loss of data, say attorneys with Morrison & Foerster LLP.